A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder

References

• Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, Secnik K. 2006. Validity of pilot adult ADHD self report scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry. 18(3):145–148.
   PubMedGoogle Scholar
• Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T. 2009. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study. J Clin Psychopharmacol. 29(3):239–247.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Publishing.
   Google Scholar
• Biederman J, Mick E, Spencer T, Surman C, Hammerness P, Doyle R, Dougherty M, Aleardi M, Schweitzer K. 2006. An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr. 11(5):390–396.
   PubMed Web of Science ®Google Scholar
• Blumberg SJ, Bramlett MD, Kogan MD, Schieve LA, Jones JR, Lu MC. 2013. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011–2012. Natl Health Stat Report. (65):1–11.
   Google Scholar
• Cambridge Cognition Limited. 2004. Cambridge neuropsychological test automated battery. Cambridge (UK): University of Cambridge.
   Google Scholar
• Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C. 1972. Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children. J Autism Dev Disord. 2(4):343–358.
   Google Scholar
• Campbell M, Small AM, Collins PJ, Friedman E, David R, Genieser N. 1976. Levodopa and levoamphetamine: a crossover study in young schizophrenic children. Curr Ther Res Clin Exp. 19(1):70–86.
   PubMed Web of Science ®Google Scholar
• Constantino JN, Gruber CP. 2012. The social responsiveness scale manual, second edition (SRS-2). Los Angeles (CA): Western Psychological Services.
   Google Scholar
• Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. 2006. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 118(4):e1203–1211.
   PubMed Web of Science ®Google Scholar
• Di Martino A, Melis G, Cianchetti C, Zuddas A. 2004. Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study. J Child Adolesc Psychopharmacol. 14(2):207–218.
   PubMed Web of Science ®Google Scholar
• Endicott J, Nee J, Harrison W, Blumenthal R. 1993. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull. 29(2):321–326.
   PubMed Web of Science ®Google Scholar
• Endicott J, Spitzer RL, Fleiss JL, Cohen J. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 33(6):766–771.
   PubMed Web of Science ®Google Scholar
• Frazier JA, Biederman J, Bellordre CA, Garfield SB, Geller DA, Coffey BJ, Faraone SV. 2001. Should the diagnosis of attention-deficit/hyperactivity disorder be considered in children with pervasive development disorder? J Atten Disord. 4(4):203–211.
   Google Scholar
• Goodman DW, Starr HL, Ma YW, Rostain AL, Ascher S, Armstrong RB. 2017. Randomized, 6-week, placebo-controlled study of treatment for adult attention-deficit/hyperactivity disorder: individualized dosing of osmotic-release oral system (OROS) methylphenidate with a goal of symptom remission. J Clin Psychiatry. 78(01):105–114.
   PubMedGoogle Scholar
• Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol. 32(1):50–55.
   PubMed Web of Science ®Google Scholar
• Handen BL, Johnson CR, Lubetsky M. 2000. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord. 30(3):245–255.
   PubMed Web of Science ®Google Scholar
• Hill EL. 2004. Executive dysfunction in autism. Trends Cogn Sci. 8(1):26–32.
   PubMed Web of Science ®Google Scholar
• Joshi G, Faraone SV, Wozniak J, Tarko L, Fried R, Galdo M. 2014. Symptom profile of ADHD in youth with high-functioning autism spectrum disorder: a comparative study in psychiatrically referred populations. J Atten Disord. 21(10):846–855.
   PubMedGoogle Scholar
• Joshi G, Petty C, Wozniak J, Henin A, Fried R, Galdo M, Kotarski M, Walls S, Biederman J. 2010. The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord. 40(11):1361–1370.
   PubMed Web of Science ®Google Scholar
• Joshi G, Wozniak J, Petty C, Martelon MK, Fried R, Bolfek A, Kotte A, Stevens J, Furtak SL, Bourgeois M, et al. 2013. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. J Autism Dev Disord. 43(6):1314–1325.
   PubMed Web of Science ®Google Scholar
• Kenworthy L, Yerys BE, Anthony LG, Wallace GL. 2008. Understanding executive control in autism spectrum disorders in the lab and in the real world. Neuropsychol Rev. 18(4):320–338.
   PubMed Web of Science ®Google Scholar
• Langworthy-Lam KS, Aman MG, Van Bourgondien ME. 2002. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. J Child Adolesc Psychopharmacol. 12(4):311–321.
   PubMed Web of Science ®Google Scholar
• Lord C, Rutter M, Le Couteur A. 1994. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 24(5):659–685.
   PubMed Web of Science ®Google Scholar
• National Institute of Mental Health 1985. CGI (Clinical Global Impression) scale - NIMH. Psychopharmacol Bull. 21(8):839–844.
   Google Scholar
• Nowicki S, Jr., Carton J. 1993. The measurement of emotional intensity from facial expressions. J Soc Psychol. 133(5):749–750.
   PubMed Web of Science ®Google Scholar
• Overall JE, Gorham DR. 1988. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychophamacology Bulletin. 24(1):97–99.
   Web of Science ®Google Scholar
• Reason JT, Manstead ASR, Stradling SG, Baxter JS, Campbell KA. 1990. Errors and violations on the road: a real distinction? Ergonomics. 33(10–11):1315–1332.
   PubMed Web of Science ®Google Scholar
• Research Units on Pediatric Psychopharmacology Autism Network 2005. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 62(11):1266–1274.
   PubMed Web of Science ®Google Scholar
• Roth RM, Isquith PK, Gioia GA. 2004. Brief-Atm Self report form. Odessa (FL): Psycholigcal Assessment Resources, Inc.
   Google Scholar
• Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S, et al. 2005. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 57(5):456–463.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, Meihua Q, Saylor KE, Brown TE, Holdnack JA, Schuh KJ, Trzepacz PT, Kelsey DK. 2010. Validation of the adult ADHD investigator symptom rating scale (AISRS). J Atten Disord. 14(1):57–68.
   PubMed Web of Science ®Google Scholar
• Stahlberg O, Soderstrom H, Rastam M, Gillberg C. 2004. Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm. 111(7):891–902.
   PubMed Web of Science ®Google Scholar
• StataCorp. 2017. Stata statistical software: release 15. College Station (TX): StataCorp LLC.
   Google Scholar
• Stigler KA, Desmond LA, Posey DJ, Wiegand RE, McDougle CJ. 2004. A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 14(1):49–56.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Koh T, Tominaga Y, Saito Y, Kashimoto Y, Matsumura T. 2014. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system methylphenidate HCl in adults with attention-deficit/hyperactivity disorder in Japan. World J Biol Psychiatry. 15(6):488–498.
   PubMed Web of Science ®Google Scholar
• Wechsler D. 1999. Wechsler abbreviated scale of intelligence (WASI). San Antonio (TX): The Psychological Corporation.
   Google Scholar
• Weissman MM, Bothwell S. 1976. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 33(9):1111–1115.
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 133:429–435.
   PubMed Web of Science ®Google Scholar